- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 8.44M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 5.26M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $390K |
| Capex | Q1 2026 · Mar 31, 2025 | $424K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.18M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.8M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.62M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $389K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$22.26M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.39M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.89M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $14.91M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $23.8M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $19.75M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.91M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $24.99M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.22M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.51 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.51 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.6M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.31M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$11.2M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.72M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.41M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.16M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.35M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $1.32M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $4.29M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $5.7M |
| Revenue | Q1 2026 · Mar 31, 2026 | $6.64M |
| Revenue | Q1 2026 · Mar 31, 2025 | $7.02M |